125.34 USD
↗ 2.62 (2.14%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
125.45
↗ 0.10 (0.08%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
125.45
↗ 0.10 (0.08%)
Market: CLOSED
INBX is currently priced at $125.28. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (260.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 26, 2026.
Open?$123.00
High?$131.01
Low?$119.44
Prev. Close?$122.72
Volume?302.9K
Avg. Volume?248.7K
VWAP?$125.87
Rel. Volume?1.22x
Bid / Ask
Bid?$122.50 × 100
Ask?$134.40 × 500
Spread?$11.90
Midpoint?$128.45
Valuation & Ratios
Market Cap?1.8B
Shares Out?14.7M
Float?9.3M
Float %?63.3%
P/E Ratio?N/A
P/B Ratio?-34.82
EPS?-$9.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Themes
Employees
110
Market Cap
1.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?7
Momentum?23
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?0.62Distress
Confidence?68%Moderate
Short InterestSqueeze Risk
Short % of Float?34.60%Squeeze Risk
Short Interest?3.2M
Days to Cover?14.4
Free Float9.3M
Avg Daily Volume223.5K
Settlement Date2026-08-14
Financial Health
Current Ratio?5.07Strong
Quick Ratio?5.07Strong
Cash Ratio?4.75Strong
Debt/Equity?-3.33Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-34.82CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-15.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?260.8%STRONG▾
Peers50
S&P97
ROA?-89.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-131899000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day